3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
7
Breast Neoplasms
4
Urothelial Cancer
2
Urinary Bladder Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasm Metastasis
2
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer
1
Non Small Cell Lung Cancer NSCLC
1
Nasopharyngeal Carcinoma
1
Metastatic Urothelial Cancer
1
Metastatic Adenocarcinoma of the Pancreas
1
Gallbladder Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma
1
Bile Duct Neoplasms
1
Interventions
Rituximab
5
Lenalidomide
3
fludarabine
2
Cyclophosphamide
2
zanubrutinib
1
venetoclax
1
umbralisib
1
ublituximab
1
tisagenlecleucel
1
tazemetostat
1
tafasitamab
1
prednisolone phosphate
1
prednisolone acetate
1
pirtobrutinib
1
obinutuzumab
1
duvelisib
1
axicabtagene ciloleucel
1
Prednisolone
1
Methylprednisolone
1
Bendamustine Hydrochloride
1
Appointments and Schedules
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Lymphoma, Follicular
×
Gemcitabine
×
Clear all
No trials found.